about
Methylfolate Trap Promotes Bacterial Thymineless Death by Sulfa DrugsTherapy of experimental meningitis due to Salmonella enteritidis.Plasmid-encoded trimethoprim resistance in staphylococci.Antimicrobial susceptibility of coagulase-negative staphylococci.Staphylococcus aureus meningitis in children: a review of 30 community-acquired cases.Concentrations of trimethoprim and sulfamethoxazole in cerebrospinal fluid and serum in mares with and without a dimethyl sulfoxide pretreatment.Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children.Clinical relevance of bacteriostatic versus bactericidal mechanisms of action in the treatment of Gram-positive bacterial infections.Drug-induced aseptic meningitis. Diagnosis leads to quick resolution.Methicillin resistance in staphylococci: molecular and biochemical basis and clinical implications.Effect of minimal amounts of thymidine on activity of trimethoprim-sulfamethoxazole against Staphylococcus epidermidis.Characterization of a staphylococcal trimethoprim resistance gene and its productMolecular epidemiology of trimethoprim resistance among coagulase-negative staphylococciListerial meningitis. Which patients are vulnerable?Pharmacokinetics of trimethoprim and sulfamethoxazole in serum and cerebrospinal fluid of adult patients with normal meninges.Trimethoprim- sulfamethoxazole: pharmacokinetics, clinical uses, and adverse reactionsMethicillin-resistant staphylococci.Chemotherapy for bacterial infections of the central nervous system.Cloning and characterization of a novel, plasmid-encoded trimethoprim-resistant dihydrofolate reductase from Staphylococcus haemolyticus MUR313.Trimethoprim-sulfamethoxazole versus vancomycin for severe infections caused by meticillin resistant Staphylococcus aureus: randomised controlled trial.Activity of new antimicrobial agents against Listeria monocytogenes.Burkholderia multivorans: A rare yet emerging cause of bacterial meningitis.Enterobacter meningitis--treatment complicated by emergence of mutants resistant to cefotaxime.Choosing antimicrobials. Factors to consider, available agents.
P2860
Q28552781-687A97AD-0C21-46CF-86E9-BE905C4FF25AQ30433367-57FB8605-34AF-4028-9D2B-316406A15D44Q33738201-EEA4544F-080D-420C-8D40-63CE18A6B1E9Q33760227-FDF0BBED-6E75-471B-986C-65A26425E676Q34053229-69BB7B57-8C71-4BFF-9681-44B7D8343F78Q34081226-41A92672-A37F-4A53-A850-9367E96DCFA6Q34157657-E966CCFF-975B-4BCE-8BAA-8C2D7EC4715CQ34303042-AD52A92A-4894-4AC3-B3C2-E809CF4BF7A7Q34982464-75A2D84A-D5E2-4A75-8E5D-70947495148BQ35376362-8D039553-C60E-4E2B-B20A-E5CAE31FCB44Q35536143-0546A556-7E53-494E-A920-FAF0F8E1235DQ35540789-6A0D1844-EE16-4077-853B-39E47911E9F4Q35543068-953C7299-047A-4E74-BA04-875F40442F84Q35555665-4CD6A817-CE91-4146-B98A-5A4CDCC31C5FQ35640897-8DE20AE2-4BC8-4783-B884-3D446D3670E8Q35690237-3F6A1F59-E3E1-4C21-AC12-14386D7BBA07Q36632851-2E5500BD-C62F-4262-81A7-DAEAB0CB62E0Q39676532-AE890455-B856-4DA3-9A77-16DA376602A8Q39780325-7A6601AD-12F8-4318-ABE6-433F9FA640B4Q40155946-9A458309-0661-4665-81FB-5087B7D1129AQ44923259-E059704B-29CA-4BBD-932B-DBE9A625C750Q52331531-0A66AB97-633F-404E-A434-721AC251849CQ54415919-F3ED102A-C916-4CAE-AA9B-846DF596889EQ54451090-CE26475A-FDB5-4C07-8816-9CC4B3DF3844
P2860
description
1984 nî lūn-bûn
@nan
1984年の論文
@ja
1984年論文
@yue
1984年論文
@zh-hant
1984年論文
@zh-hk
1984年論文
@zh-mo
1984年論文
@zh-tw
1984年论文
@wuu
1984年论文
@zh
1984年论文
@zh-cn
name
Trimethoprim-sulfamethoxazole for bacterial meningitis.
@en
type
label
Trimethoprim-sulfamethoxazole for bacterial meningitis.
@en
prefLabel
Trimethoprim-sulfamethoxazole for bacterial meningitis.
@en
P1476
Trimethoprim-sulfamethoxazole for bacterial meningitis.
@en
P2093
Quintiliani R
P304
P356
10.7326/0003-4819-100-6-881
P407
P577
1984-06-01T00:00:00Z